Angioplasty Balloons Market Analysis & Forecast: 2026-2033

Angioplasty Balloons Market Size and Forecast – 2026 – 2033

The Global Angioplasty Balloons Market size is estimated to be valued at USD 2.15 billion in 2026 and is expected to reach USD 3.60 billion by 2033, exhibiting a compound annual growth rate (CAGR) of 7.5% from 2026 to 2033.

Global Angioplasty Balloons Market Overview

The angioplasty balloons market comprises devices designed for percutaneous coronary and peripheral interventions to restore blood flow in narrowed or blocked arteries. Key product categories include conventional balloons, drug-coated balloons (DCB), cutting and scoring balloons, and specialty balloons tailored for complex lesions. Conventional balloons are widely used for basic dilation procedures, while drug-coated balloons release antiproliferative agents to reduce restenosis risk. Cutting and scoring balloons feature microblades or scoring elements to modify plaque, enhancing procedural efficacy in resistant lesions. Specialty balloons cater to niche applications such as bifurcation or chronic total occlusion cases. Products are available in various diameters and lengths to match patient-specific anatomical requirements.

Key Takeaways

• Non-Compliant Balloons segment leads with 45% market share, driven by procedural efficiency and versatile applications.

• Drug-Coated Balloons are the fastest-growing segment, improving therapeutic outcomes in both coronary and peripheral interventions.

• North America dominates the market, holding over 38% of the industry share, supported by advanced healthcare infrastructure and favorable regulatory approvals.

• Asia Pacific exhibits the fastest regional CAGR, driven by expanding healthcare access and increasing prevalence of cardiovascular diseases in countries such as China and India.

Angioplasty Balloons Market Segmentation Analysis

To learn more about this report, Download Free Sample

Angioplasty Balloons Market Insights, By Balloon Type

Non-Compliant Balloons dominate the angioplasty balloons market with a 45% share, largely due to their precise diameter control and ability to withstand higher inflation pressures, making them ideal for treating severe arterial blockages. Drug-Coated Balloons are the fastest-growing subsegment, valued for reducing restenosis rates and gaining widespread clinical adoption in coronary and peripheral interventions. Compliant Balloons offer greater flexibility but are limited in high-pressure applications, while Semi-Compliant Balloons provide a balance between flexibility and pressure tolerance for moderate lesions.

Angioplasty Balloons Market Insights, By Product Material

Polyamide leads the angioplasty balloons market as the preferred material, thanks to its high tensile strength, flexibility, and suitability for precision coronary procedures. Nylon is the fastest-growing segment, increasingly used in balloon catheters for peripheral artery treatments where elasticity, puncture resistance, and durability are critical. Polyester offers cost-effective solutions with moderate performance, while Polyurethane provides excellent biocompatibility but limited expansion capacity, restricting its use in high-pressure applications.

Angioplasty Balloons Market Insights, By Application

The Coronary segment dominates the angioplasty balloons market due to the high global prevalence of coronary artery disease, resulting in substantial procedural volumes and significant market share. Peripheral angioplasty balloons are the fastest-growing application segment, driven by increasing cases of peripheral artery disease among aging populations and the expansion of clinical indications for limb salvage and vascular restoration. The Others category includes interventions in renal, carotid, and other smaller vascular territories. Although currently representing a smaller portion of the market, these applications are experiencing gradual adoption fueled by innovations in balloon design, delivery systems, and improved clinical outcomes, signaling future growth potential.

Angioplasty Balloons Market Trends

• Recent trends indicate a move toward personalized angioplasty balloons designed for lesion-specific treatments, with clinical trials in Japan (2024) showing improved patient outcomes.

• Drug-coated and bioresorbable balloons are gaining popularity, enhancing procedural safety and supporting wider adoption of angioplasty interventions.

• There is an increasing focus on minimally invasive and targeted therapies to improve efficacy and reduce post-procedural complications.

• Digitization of supply chains is improving product availability, reducing lead times, and optimizing inventory management in key regions.

• North America and Europe are leading the adoption of advanced logistics and distribution systems, supporting efficient delivery of angioplasty balloons to healthcare facilities.

Angioplasty Balloons Market Insights, By Geography

To learn more about this report, Download Free Sample

North America Angioplasty Balloons Market Analysis and Trends

North America dominates the angioplasty balloons market, supported by advanced hospital infrastructure, well-established healthcare systems, favorable reimbursement policies, and streamlined regulatory approvals. The region contributes approximately 38% of total market revenue, reflecting high procedural volumes and widespread adoption of technologically advanced devices. Major industry players, including Abbott Laboratories and Boston Scientific, are headquartered in North America, driving market growth through continuous product innovation, clinical trials, and collaborations with healthcare providers. The presence of strong research and development capabilities and early adoption of drug-coated, non-compliant, and bioresorbable balloons further strengthens the region’s market leadership, making it a key hub for angioplasty balloon advancements.

Asia Pacific Angioplasty Balloons Market Analysis and Trends

The Asia Pacific angioplasty balloons market is experiencing the fastest growth, with a projected CAGR exceeding 9%, driven by expanding healthcare infrastructure, rising prevalence of cardiovascular diseases, and increased government investments in healthcare across countries such as China and India. Growing awareness of minimally invasive interventions and improved access to advanced cardiac care are further boosting adoption. Leading market players, including Terumo Corporation and Lepu Medical, are actively expanding manufacturing capacities, distribution channels, and localized product offerings to meet rising demand. These strategic initiatives enhance market competition, accelerate regional growth, and position Asia Pacific as a key emerging hub in the global angioplasty balloons industry.

Angioplasty Balloons Market Outlook for Key Countries

USA Angioplasty Balloons Market Analysis and Trends

The USA’s angioplasty balloons market continues to be the largest globally, supported by advanced healthcare infrastructure and a high annual volume of cardiovascular procedures, exceeding 1.2 million interventions in 2025. Market growth is reinforced by continuous product innovations, including FDA-approved drug-coated balloons and bioresorbable devices, which enhance procedural safety and success rates. Major players such as Medtronic and Boston Scientific strengthen their market position through strategic partnerships with hospitals, clinical research collaborations, and targeted product launches. These efforts drive revenue growth, expand market share, and maintain the country’s leadership in the global angioplasty balloons industry while fostering adoption of advanced interventional technologies.

Germany Angioplasty Balloons Market Analysis and Trends

Germany’s angioplasty balloons market is growing steadily, driven by high cardiovascular disease prevalence, advanced hospital infrastructure, and well-established interventional cardiology programs. The market sees strong demand for drug-coated and non-compliant balloons due to their clinical efficacy in complex coronary and peripheral procedures. Regulatory compliance under the European Union and robust reimbursement frameworks support widespread adoption of advanced devices. Innovations such as bioresorbable and lesion-specific balloons are gaining traction, catering to personalized treatment approaches. Increasing collaborations between device manufacturers and healthcare institutions, along with rising awareness of minimally invasive interventions, further stimulate market growth. Germany remains a key contributor to Europe’s angioplasty balloons market.

Analyst Opinion

• Rising clinical interventions for cardiovascular diseases have increased demand for angioplasty balloons in hospitals and ambulatory surgical centers. In 2025, over 1.2 million angioplasty procedures were performed in the U.S., with innovative devices like drug-coated balloons commanding a 6% average price premium, driving market value growth.

• Technological advancements, including ultra-thin balloon designs and improved compliance profiles, have boosted deployment rates. Capacity expansions in Asia Pacific manufacturing hubs, particularly China and India, increased global production by 15% in 2024, strengthening supply-side support and revenue growth.

• Regulatory approvals in North America and Europe for novel balloons, such as bioresorbable and drug-eluting types, have expanded regional market shares. FDA approval of a next-generation drug-coated balloon in early 2026 led to a 10% rise in U.S. imports.

• Import-export trends indicate market dynamics, with Germany and Japan importing high-end angioplasty balloons to support healthcare infrastructure, while Southeast Asian manufacturing hubs saw a 12% increase in exports in 2025, reflecting a balanced global trade ecosystem.

Market Scope

Angioplasty Balloons Market Growth Factors

The angioplasty balloons market is primarily driven by the rising prevalence of cardiovascular diseases, influenced by aging populations and lifestyle-related risk factors such as diabetes and hypertension. Technological innovations, including drug-coated and bioresorbable balloons, are improving clinical outcomes and reducing restenosis rates, thereby stimulating market growth. Expanding healthcare access and infrastructure in emerging economies is increasing procedural adoption, directly contributing to revenue expansion. Additionally, ongoing clinical trials and real-world evidence supporting the safety and efficacy of advanced balloon technologies are addressing previous concerns, further encouraging adoption. These factors collectively reinforce sustained market development and future growth potential.

Angioplasty Balloons Market Development

In August 2025, Boston Scientific announced the launch of the AGENT DCB STANCE trial to evaluate the safety and effectiveness of the AGENT drug-coated balloon versus standard care, including PCI with drug-eluting stents and/or balloon angioplasty.

Key Players

Leading Companies of the Market

• Medtronic plc

• Abbott Laboratories

• Philips Healthcare

• Guerbet Group

• Cook Medical

• NuMED Inc.

• Terumo Corporation

• Minvasys, Inc.

• Sirtex Medical Ltd.

• Accumedical Technologies

Leading market players in the angioplasty balloons industry have pursued competitive strategies that combine innovation with aggressive product launches. In 2025, Medtronic strategically launched enhanced drug-coated balloons, resulting in a 9% increase in market revenue in North America. Similarly, Boston Scientific invested in expanding manufacturing capabilities across the Asia Pacific region in 2024, which contributed to a 13% rise in regional market share. These initiatives underscore how major companies leverage product innovation, capacity expansion, and strategic regional focus to drive growth, strengthen market positioning, and capture emerging opportunities in the global angioplasty balloons market.

Angioplasty Balloons Market Future Outlook

The future outlook for the angioplasty balloons market is highly promising, driven by rising cardiovascular disease prevalence, aging populations, and increasing adoption of minimally invasive interventions. Technological advancements, including drug-coated, bioresorbable, and ultra-thin balloons, are enhancing procedural safety, efficacy, and patient outcomes. Emerging trends such as personalized devices tailored to lesion-specific treatments and integration with digital health monitoring are expected to reshape the market. Expanding healthcare infrastructure and reimbursement support in emerging economies, particularly in Asia Pacific, will further drive adoption. Overall, sustained innovation, regional market expansion, and growing clinical awareness are poised to fuel long-term growth and market diversification.

Angioplasty Balloons Market Historical Analysis

The angioplasty balloons market has experienced steady growth over the past decade, primarily driven by rising cardiovascular disease prevalence and advancements in interventional cardiology. Historically, conventional and non-compliant balloons dominated due to their reliability in standard coronary procedures, while early adoption of drug-coated and semi-compliant balloons gradually increased. North America led the market owing to advanced healthcare infrastructure, high procedural volumes, and favorable reimbursement policies, followed by Europe and Asia Pacific. Technological innovations, such as improved balloon materials and delivery systems, along with expanding clinical applications in peripheral and complex lesions, have shaped historical market trends, laying the foundation for current growth and future opportunities.

Sources

• Primary Research Interviews:

• Interventional cardiologists and catheterization lab specialists

• Hospital procurement managers and distributors of cardiovascular devices

• Clinical researchers and biomedical engineers focusing on cardiovascular interventions

• Magazines:

• Medical Device and Diagnostic Industry (MD+DI) – Cardiovascular Device Updates

• Cardiovascular Business – Market News and Innovations

• Endovascular Today – Interventional Cardiology Procedures and Technology

• MedTech Outlook – Advances in Cardiovascular Devices

• Journals:

• Journal of Interventional Cardiology – Clinical and Device Research

• Catheterization and Cardiovascular Interventions – Procedural and Device Studies

• Circulation: Cardiovascular Interventions – Efficacy and Safety Studies

• European Heart Journal – Innovations in Coronary and Peripheral Interventions

• Newspapers:

• The Wall Street Journal – Medical Device and Healthcare Industry Updates

• Financial Times – Healthcare Technology and Market Developments

• Reuters – Cardiovascular Device Market News

• Bloomberg – Medical Technology and Industry Trends

• Associations:

• American College of Cardiology (ACC) – Clinical Guidelines and Device Standards

• European Society of Cardiology (ESC) – Cardiovascular Device Research and Policies

• Society for Cardiovascular Angiography and Interventions (SCAI)

• Medical Device Manufacturers Association (MDMA) – Regulatory and Industry Standards